WASHINGTON, DC – The Center for Strategic and International Studies (CSIS), a bipartisan, nonprofit policy research organization dedicated to advancing practical ideas to address the world’s greatest ...

The Supreme Court on Tuesday dismissed appeals in the 2002 death case of actress Prathyusha, ruling out murder and affirming Gudipalli Siddhartha Reddy’s conviction for abetment of suicide. Reddy ...

In a significant ruling that brought closure to a 23-year-old legal tussle, the Supreme Court of India, on Tuesday dismissed the appeal filed by Gudipalli Siddhartha Reddy challenging his conviction ...

HYDERABAD, Feb 17 (Reuters) - Indian drugmaker Dr Reddy’s Laboratories (REDY.NS), opens new tab hopes to launch a generic version of Novo Nordisk’s (NOVOb.CO), opens new tab blockbuster weight‑loss ...

HYDERABAD, Feb ‌17 (Reuters) - Indian drugmaker ‌Dr Reddy's laboratories aims to launch a generic version of Novo Nordisk's blockbuster weight loss ‌drug Wegovy, ⁠subject to approval, at a price ...

Dr. Reddy’s Laboratories is paying $20 million upfront for the rights to Immutep’s phase 3-stage LAG-3 candidate in certain territories while leaving the Australian biotech with ownership in key ...

What are music’s biggest global artist stories of 2025? Here’s a trio for you: Taylor Swift’s record-shattering The Life Of A Showgirl; Bad Bunny’s culture-defining residency in Puerto Rico (and ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min AAR's $78M acquisition of HAECO ...

Anil Sharma’s Lila Global has recruited dry bulk veteran Navin Arjun Soni as chief commercial officer. Soni, who until recently headed Heidmar’s Singapore office, where he spent nearly three years ...

India’s Dr Reddy’s Laboratories Ltd. is gearing up to launch a generic version of semaglutide — the active ingredient in Novo Nordisk A/S’s blockbuster weight-loss drug Wegovy — next year, joining ...